Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable ...
The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable ...
In a recent study published in Circulation, researchers estimate the change in the severe heat-related cardiovascular mortality burden in the ...
Forget walking 10,000 steps a day. Taking at least 50 steps climbing stairs each day could significantly slash your risk ...
Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at ...
Physiology-guided complete revascularization reduces ischemic events compared with culprit-only revascularization in myocardial (MI) infarction patients aged 75 years or older ...
Patients with diabetes and a history of metabolic surgery had significantly fewer heart attacks, strokes, hospitalizations and death compared to ...
In a recent study published in BMJ Open, researchers assess self-documented post-coronavirus disease 2019 (COVID-19) syndrome (PCS) or long COVID ...
Women are more than twice as likely to die after a heart attack than men, according to research presented today ...
In a recent study published in the Current Hypertensive Reports Journal, researchers performed a systematic review to evaluate the impact ...
Young women who experience a heart attack have more adverse outcomes and are more likely to end up back in ...
Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023)...
Read moreNEWS RELEASE: Dinsmore Earns Distinction as HP Digital Manufacturing Partner Dinsmore EVP Jay Dinsmore (left) and Greg Elfering, Head of...
Read moreScientists have developed a potentially transformative new technique that could aid in the discovery and development of new therapeutics for...
Read moreMedtronic SVP and President of Coronary and Renal Denervation Jason Weidman It took Medtronic nearly 13 years to win FDA...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.